Introduction Biologic and small-molecule therapies have revolutionised the treatment of moderate-to-severe inflammatory bowel disease (IBD). A significant proportion of patients experience early or delayed treatment failure. Patients with IBD with greater visceral obesity are less likely to respond to biologics. https://www.bekindtopets.com/bargain-Taters-Over-Haters-Comfort-Colors-Adult-Ring-Spun-Cotton-Tee-best-find/